Showing results (131-140 of 244) with videos related to
Sort By:
Pageof 25
Patient Preference and Adherence|October 16, 2020
Knowledge About Immunosuppressant Medication and Its Correlates in a German Kidney Transplant Population - Results of a KTx360° SubstudySophie de Boer, Felix Klewitz, Maximilian Bauer-Hohmann, et al.Journal of Visualized Experiments : Jove|August 8, 2022
A Modified Surgical Technique for Kidney Transplantation in MiceDecheng Yin, Jian Fu, Rongjun Chen, et al.Therapeutic Advances in Chronic Disease|May 5, 2021
Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial <sup>23</sup>Na-MRI investigationJulia Moosmann, Okan Toka, Peter Linz, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex depositionLena Schiffer, Jayashree Sinha, Xiaobo Wang, et al.JCI Insight|June 10, 2025
Cytoskeleton-associated protein 4 (CKAP4) affects podocyte cytoskeleton dynamics in diabetic kidney diseaseRoberto Boi, Emelie Lassén, Alva Johansson, et al.Cardiovascular Diabetology|September 5, 2021
Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargineChristian Ott, Susanne Jung, Manuel Korn, et al.ESC Heart Failure|September 20, 2021
Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failureJulie Kolwelter, Agnes Bosch, Susanne Jung, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 20, 2024
PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular diseaseDennis Kannenkeril, Agnes Bosch, Julie Kolwelter, et al.Kidney International Reports|May 6, 2024
Modification of Dialysate Na<sup>+</sup> Concentration but not Ultrafiltration or Dialysis Treatment Time Affects Tissue Na<sup>+</sup> Deposition in Patients on HemodialysisChristoph Kopp, Lukas Kittler, Peter Linz, et al.Thrombosis and Haemostasis|November 1, 2013
Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS)Alexander Lukasz, Jan Beneke, Jan Menne, et al.Pageof 25